China's Control Over Medicines Raises Concerns
The article highlights the United States’ dependence on China for critical pharmaceutical ingredients, with China controlling nearly half of the global market. Experts warn that this reliance poses national security risks, including the potential weaponization of supply chains, as Chinese networks also supply fentanyl precursors. The article calls for increased investment in domestic pharmaceutical manufacturing to restore independence and safeguard public health and national security.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading